nodes	percent_of_prediction	percent_of_DWPC	metapath
Flurazepam—GABRR3—peripheral nervous system—amyotrophic lateral sclerosis	0.0227	0.062	CbGeAlD
Flurazepam—GABRR2—peripheral nervous system—amyotrophic lateral sclerosis	0.0197	0.0537	CbGeAlD
Flurazepam—GABRR1—peripheral nervous system—amyotrophic lateral sclerosis	0.019	0.0517	CbGeAlD
Flurazepam—Upset stomach—Riluzole—amyotrophic lateral sclerosis	0.018	0.0615	CcSEcCtD
Flurazepam—GABRQ—nerve—amyotrophic lateral sclerosis	0.0177	0.0483	CbGeAlD
Flurazepam—GABRR3—nerve—amyotrophic lateral sclerosis	0.0177	0.0483	CbGeAlD
Flurazepam—GABRR2—nerve—amyotrophic lateral sclerosis	0.0154	0.0419	CbGeAlD
Flurazepam—GABRR1—nerve—amyotrophic lateral sclerosis	0.0148	0.0403	CbGeAlD
Flurazepam—Thinking abnormal—Riluzole—amyotrophic lateral sclerosis	0.0129	0.044	CcSEcCtD
Flurazepam—Dysarthria—Riluzole—amyotrophic lateral sclerosis	0.0124	0.0426	CcSEcCtD
Flurazepam—Gait disturbance—Riluzole—amyotrophic lateral sclerosis	0.0121	0.0413	CcSEcCtD
Flurazepam—Phosphatase alkaline increased—Riluzole—amyotrophic lateral sclerosis	0.0118	0.0403	CcSEcCtD
Flurazepam—Coma—Riluzole—amyotrophic lateral sclerosis	0.0107	0.0368	CcSEcCtD
Flurazepam—Mental disability—Riluzole—amyotrophic lateral sclerosis	0.0102	0.035	CcSEcCtD
Flurazepam—Euphoric mood—Riluzole—amyotrophic lateral sclerosis	0.0101	0.0346	CcSEcCtD
Flurazepam—Blood alkaline phosphatase increased—Riluzole—amyotrophic lateral sclerosis	0.00982	0.0337	CcSEcCtD
Flurazepam—GABRA6—hindbrain—amyotrophic lateral sclerosis	0.00921	0.0251	CbGeAlD
Flurazepam—Anaphylactoid reaction—Riluzole—amyotrophic lateral sclerosis	0.00882	0.0302	CcSEcCtD
Flurazepam—Ataxia—Riluzole—amyotrophic lateral sclerosis	0.00803	0.0275	CcSEcCtD
Flurazepam—Aspartate aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.00769	0.0264	CcSEcCtD
Flurazepam—Abdominal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00708	0.0243	CcSEcCtD
Flurazepam—Quinacrine—PLA2G4A—amyotrophic lateral sclerosis	0.00688	0.456	CrCbGaD
Flurazepam—GABRB2—hindbrain—amyotrophic lateral sclerosis	0.00678	0.0185	CbGeAlD
Flurazepam—Clobazam—SLC6A1—amyotrophic lateral sclerosis	0.0066	0.438	CrCbGaD
Flurazepam—Sweating—Riluzole—amyotrophic lateral sclerosis	0.00631	0.0216	CcSEcCtD
Flurazepam—GABRA2—hindbrain—amyotrophic lateral sclerosis	0.0062	0.0169	CbGeAlD
Flurazepam—Agranulocytosis—Riluzole—amyotrophic lateral sclerosis	0.00614	0.0211	CcSEcCtD
Flurazepam—GABRA1—hindbrain—amyotrophic lateral sclerosis	0.00599	0.0163	CbGeAlD
Flurazepam—Hallucination—Riluzole—amyotrophic lateral sclerosis	0.00588	0.0201	CcSEcCtD
Flurazepam—GABRA6—brainstem—amyotrophic lateral sclerosis	0.00528	0.0144	CbGeAlD
Flurazepam—Tension—Riluzole—amyotrophic lateral sclerosis	0.00505	0.0173	CcSEcCtD
Flurazepam—Dysgeusia—Riluzole—amyotrophic lateral sclerosis	0.00504	0.0173	CcSEcCtD
Flurazepam—Nervousness—Riluzole—amyotrophic lateral sclerosis	0.00499	0.0171	CcSEcCtD
Flurazepam—Agitation—Riluzole—amyotrophic lateral sclerosis	0.00473	0.0162	CcSEcCtD
Flurazepam—Syncope—Riluzole—amyotrophic lateral sclerosis	0.00461	0.0158	CcSEcCtD
Flurazepam—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.0046	0.0158	CcSEcCtD
Flurazepam—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.00454	0.0156	CcSEcCtD
Flurazepam—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.00452	0.0155	CcSEcCtD
Flurazepam—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.00438	0.015	CcSEcCtD
Flurazepam—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.00438	0.015	CcSEcCtD
Flurazepam—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.00436	0.015	CcSEcCtD
Flurazepam—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.00428	0.0147	CcSEcCtD
Flurazepam—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.00423	0.0145	CcSEcCtD
Flurazepam—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.0042	0.0144	CcSEcCtD
Flurazepam—Shock—Riluzole—amyotrophic lateral sclerosis	0.00413	0.0142	CcSEcCtD
Flurazepam—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.00406	0.0139	CcSEcCtD
Flurazepam—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.004	0.0137	CcSEcCtD
Flurazepam—GABRQ—nervous system—amyotrophic lateral sclerosis	0.00398	0.0109	CbGeAlD
Flurazepam—GABRR3—nervous system—amyotrophic lateral sclerosis	0.00398	0.0109	CbGeAlD
Flurazepam—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.00392	0.0134	CcSEcCtD
Flurazepam—GABRB2—brainstem—amyotrophic lateral sclerosis	0.00389	0.0106	CbGeAlD
Flurazepam—GABRD—medulla oblongata—amyotrophic lateral sclerosis	0.00385	0.0105	CbGeAlD
Flurazepam—GABRQ—central nervous system—amyotrophic lateral sclerosis	0.00384	0.0105	CbGeAlD
Flurazepam—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00382	0.0131	CcSEcCtD
Flurazepam—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.00374	0.0128	CcSEcCtD
Flurazepam—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.00373	0.0128	CcSEcCtD
Flurazepam—GABRG1—medulla oblongata—amyotrophic lateral sclerosis	0.0037	0.0101	CbGeAlD
Flurazepam—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.00369	0.0127	CcSEcCtD
Flurazepam—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.00365	0.0125	CcSEcCtD
Flurazepam—GABRB1—medulla oblongata—amyotrophic lateral sclerosis	0.00359	0.00979	CbGeAlD
Flurazepam—Constipation—Riluzole—amyotrophic lateral sclerosis	0.00359	0.0123	CcSEcCtD
Flurazepam—GABRA2—brainstem—amyotrophic lateral sclerosis	0.00355	0.00968	CbGeAlD
Flurazepam—GABRG3—nervous system—amyotrophic lateral sclerosis	0.00349	0.00951	CbGeAlD
Flurazepam—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.00346	0.0119	CcSEcCtD
Flurazepam—GABRR2—nervous system—amyotrophic lateral sclerosis	0.00346	0.00942	CbGeAlD
Flurazepam—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.00343	0.0118	CcSEcCtD
Flurazepam—GABRA1—brainstem—amyotrophic lateral sclerosis	0.00343	0.00936	CbGeAlD
Flurazepam—GABRG3—central nervous system—amyotrophic lateral sclerosis	0.00336	0.00916	CbGeAlD
Flurazepam—GABRR1—nervous system—amyotrophic lateral sclerosis	0.00333	0.00907	CbGeAlD
Flurazepam—GABRG1—spinal cord—amyotrophic lateral sclerosis	0.0033	0.009	CbGeAlD
Flurazepam—GABRR2—cerebellum—amyotrophic lateral sclerosis	0.00325	0.00886	CbGeAlD
Flurazepam—GABRR1—central nervous system—amyotrophic lateral sclerosis	0.0032	0.00873	CbGeAlD
Flurazepam—GABRB1—spinal cord—amyotrophic lateral sclerosis	0.0032	0.00873	CbGeAlD
Flurazepam—GABRQ—brain—amyotrophic lateral sclerosis	0.00305	0.0083	CbGeAlD
Flurazepam—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00301	0.0103	CcSEcCtD
Flurazepam—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.00297	0.0102	CcSEcCtD
Flurazepam—GABRD—nervous system—amyotrophic lateral sclerosis	0.00289	0.00788	CbGeAlD
Flurazepam—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.00287	0.00984	CcSEcCtD
Flurazepam—GABRD—central nervous system—amyotrophic lateral sclerosis	0.00278	0.00759	CbGeAlD
Flurazepam—GABRG1—nervous system—amyotrophic lateral sclerosis	0.00278	0.00758	CbGeAlD
Flurazepam—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00278	0.00951	CcSEcCtD
Flurazepam—GABRA6—nervous system—amyotrophic lateral sclerosis	0.00277	0.00754	CbGeAlD
Flurazepam—GABRD—cerebellum—amyotrophic lateral sclerosis	0.00272	0.00741	CbGeAlD
Flurazepam—GABRB2—medulla oblongata—amyotrophic lateral sclerosis	0.00271	0.00739	CbGeAlD
Flurazepam—GABRG2—medulla oblongata—amyotrophic lateral sclerosis	0.00271	0.00739	CbGeAlD
Flurazepam—GABRB1—nervous system—amyotrophic lateral sclerosis	0.0027	0.00735	CbGeAlD
Flurazepam—GABRA5—nervous system—amyotrophic lateral sclerosis	0.00268	0.00731	CbGeAlD
Flurazepam—GABRG1—central nervous system—amyotrophic lateral sclerosis	0.00268	0.0073	CbGeAlD
Flurazepam—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00267	0.00915	CcSEcCtD
Flurazepam—GABRG3—brain—amyotrophic lateral sclerosis	0.00267	0.00727	CbGeAlD
Flurazepam—GABRA6—central nervous system—amyotrophic lateral sclerosis	0.00266	0.00726	CbGeAlD
Flurazepam—Rash—Riluzole—amyotrophic lateral sclerosis	0.00265	0.00907	CcSEcCtD
Flurazepam—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00264	0.00906	CcSEcCtD
Flurazepam—Headache—Riluzole—amyotrophic lateral sclerosis	0.00263	0.00901	CcSEcCtD
Flurazepam—GABRG1—cerebellum—amyotrophic lateral sclerosis	0.00262	0.00714	CbGeAlD
Flurazepam—GABRA6—cerebellum—amyotrophic lateral sclerosis	0.0026	0.0071	CbGeAlD
Flurazepam—GABRB1—central nervous system—amyotrophic lateral sclerosis	0.0026	0.00708	CbGeAlD
Flurazepam—GABRA5—central nervous system—amyotrophic lateral sclerosis	0.00258	0.00704	CbGeAlD
Flurazepam—GABRR1—brain—amyotrophic lateral sclerosis	0.00254	0.00693	CbGeAlD
Flurazepam—GABRB1—cerebellum—amyotrophic lateral sclerosis	0.00254	0.00692	CbGeAlD
Flurazepam—GABRA3—nervous system—amyotrophic lateral sclerosis	0.0025	0.00681	CbGeAlD
Flurazepam—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00249	0.00855	CcSEcCtD
Flurazepam—GABRA4—nervous system—amyotrophic lateral sclerosis	0.00243	0.00664	CbGeAlD
Flurazepam—GABRB2—spinal cord—amyotrophic lateral sclerosis	0.00242	0.00659	CbGeAlD
Flurazepam—GABRG2—spinal cord—amyotrophic lateral sclerosis	0.00242	0.00659	CbGeAlD
Flurazepam—GABRA3—central nervous system—amyotrophic lateral sclerosis	0.00241	0.00656	CbGeAlD
Flurazepam—GABRA1—medulla oblongata—amyotrophic lateral sclerosis	0.00239	0.00652	CbGeAlD
Flurazepam—GABRA4—central nervous system—amyotrophic lateral sclerosis	0.00234	0.00639	CbGeAlD
Flurazepam—GABRA4—cerebellum—amyotrophic lateral sclerosis	0.00229	0.00624	CbGeAlD
Flurazepam—GABRD—brain—amyotrophic lateral sclerosis	0.00221	0.00602	CbGeAlD
Flurazepam—GABRA1—spinal cord—amyotrophic lateral sclerosis	0.00213	0.00582	CbGeAlD
Flurazepam—GABRG1—brain—amyotrophic lateral sclerosis	0.00213	0.0058	CbGeAlD
Flurazepam—GABRA6—brain—amyotrophic lateral sclerosis	0.00211	0.00576	CbGeAlD
Flurazepam—GABRB3—medulla oblongata—amyotrophic lateral sclerosis	0.00208	0.00567	CbGeAlD
Flurazepam—GABRB1—brain—amyotrophic lateral sclerosis	0.00206	0.00562	CbGeAlD
Flurazepam—GABRA5—brain—amyotrophic lateral sclerosis	0.00205	0.00559	CbGeAlD
Flurazepam—GABRB2—nervous system—amyotrophic lateral sclerosis	0.00204	0.00555	CbGeAlD
Flurazepam—GABRG2—nervous system—amyotrophic lateral sclerosis	0.00204	0.00555	CbGeAlD
Flurazepam—CYP2A6—cerebellum—amyotrophic lateral sclerosis	0.00198	0.0054	CbGeAlD
Flurazepam—GABRB2—central nervous system—amyotrophic lateral sclerosis	0.00196	0.00534	CbGeAlD
Flurazepam—GABRG2—central nervous system—amyotrophic lateral sclerosis	0.00196	0.00534	CbGeAlD
Flurazepam—GABRB2—cerebellum—amyotrophic lateral sclerosis	0.00192	0.00522	CbGeAlD
Flurazepam—GABRG2—cerebellum—amyotrophic lateral sclerosis	0.00192	0.00522	CbGeAlD
Flurazepam—GABRA3—brain—amyotrophic lateral sclerosis	0.00191	0.0052	CbGeAlD
Flurazepam—GABRA4—brain—amyotrophic lateral sclerosis	0.00186	0.00507	CbGeAlD
Flurazepam—GABRA2—nervous system—amyotrophic lateral sclerosis	0.00186	0.00507	CbGeAlD
Flurazepam—GABRB3—spinal cord—amyotrophic lateral sclerosis	0.00186	0.00506	CbGeAlD
Flurazepam—GABRE—nervous system—amyotrophic lateral sclerosis	0.00184	0.00503	CbGeAlD
Flurazepam—GABRA1—nervous system—amyotrophic lateral sclerosis	0.0018	0.0049	CbGeAlD
Flurazepam—GABRA2—central nervous system—amyotrophic lateral sclerosis	0.00179	0.00488	CbGeAlD
Flurazepam—GABRE—central nervous system—amyotrophic lateral sclerosis	0.00178	0.00484	CbGeAlD
Flurazepam—GABRA2—cerebellum—amyotrophic lateral sclerosis	0.00175	0.00477	CbGeAlD
Flurazepam—GABRA1—central nervous system—amyotrophic lateral sclerosis	0.00173	0.00472	CbGeAlD
Flurazepam—GABRA1—cerebellum—amyotrophic lateral sclerosis	0.00169	0.00461	CbGeAlD
Flurazepam—CYP2A6—brain—amyotrophic lateral sclerosis	0.00161	0.00439	CbGeAlD
Flurazepam—Clomipramine—GSTP1—amyotrophic lateral sclerosis	0.0016	0.106	CrCbGaD
Flurazepam—GABRB3—nervous system—amyotrophic lateral sclerosis	0.00156	0.00426	CbGeAlD
Flurazepam—GABRB2—brain—amyotrophic lateral sclerosis	0.00156	0.00424	CbGeAlD
Flurazepam—GABRG2—brain—amyotrophic lateral sclerosis	0.00156	0.00424	CbGeAlD
Flurazepam—GABRB3—central nervous system—amyotrophic lateral sclerosis	0.00151	0.0041	CbGeAlD
Flurazepam—GABRB3—cerebellum—amyotrophic lateral sclerosis	0.00147	0.00401	CbGeAlD
Flurazepam—GABRA2—brain—amyotrophic lateral sclerosis	0.00142	0.00388	CbGeAlD
Flurazepam—GABRE—brain—amyotrophic lateral sclerosis	0.00141	0.00384	CbGeAlD
Flurazepam—GABRA1—brain—amyotrophic lateral sclerosis	0.00137	0.00375	CbGeAlD
Flurazepam—CYP2E1—medulla oblongata—amyotrophic lateral sclerosis	0.00132	0.00361	CbGeAlD
Flurazepam—GABRB3—brain—amyotrophic lateral sclerosis	0.0012	0.00326	CbGeAlD
Flurazepam—CYP2E1—spinal cord—amyotrophic lateral sclerosis	0.00118	0.00322	CbGeAlD
Flurazepam—ABCB1—embryo—amyotrophic lateral sclerosis	0.00118	0.00322	CbGeAlD
Flurazepam—CYP2E1—nervous system—amyotrophic lateral sclerosis	0.000995	0.00271	CbGeAlD
Flurazepam—CYP2E1—central nervous system—amyotrophic lateral sclerosis	0.000958	0.00261	CbGeAlD
Flurazepam—CYP2E1—cerebellum—amyotrophic lateral sclerosis	0.000936	0.00255	CbGeAlD
Flurazepam—CYP3A4—nervous system—amyotrophic lateral sclerosis	0.000801	0.00218	CbGeAlD
Flurazepam—CYP3A4—central nervous system—amyotrophic lateral sclerosis	0.000771	0.0021	CbGeAlD
Flurazepam—CYP2E1—brain—amyotrophic lateral sclerosis	0.00076	0.00207	CbGeAlD
Flurazepam—ABCB1—medulla oblongata—amyotrophic lateral sclerosis	0.000754	0.00206	CbGeAlD
Flurazepam—ABCB1—spinal cord—amyotrophic lateral sclerosis	0.000673	0.00183	CbGeAlD
Flurazepam—GABRB2—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.000597	0.00183	CbGpPWpGaD
Flurazepam—GABRA3—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.000596	0.00183	CbGpPWpGaD
Flurazepam—GABRB1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000589	0.0018	CbGpPWpGaD
Flurazepam—GABRA5—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000586	0.0018	CbGpPWpGaD
Flurazepam—GABRA2—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.000586	0.00179	CbGpPWpGaD
Flurazepam—GABRB3—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.000582	0.00178	CbGpPWpGaD
Flurazepam—GABRA5—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.00058	0.00178	CbGpPWpGaD
Flurazepam—SLC22A2—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.000578	0.00177	CbGpPWpGaD
Flurazepam—GABRA1—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.000576	0.00176	CbGpPWpGaD
Flurazepam—GABRA3—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000575	0.00176	CbGpPWpGaD
Flurazepam—GABRG2—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.000571	0.00175	CbGpPWpGaD
Flurazepam—GABRA3—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.000569	0.00174	CbGpPWpGaD
Flurazepam—GABRA6—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000568	0.00174	CbGpPWpGaD
Flurazepam—GABRA6—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000568	0.00174	CbGpPWpGaD
Flurazepam—ABCB1—nervous system—amyotrophic lateral sclerosis	0.000567	0.00154	CbGeAlD
Flurazepam—GABRA2—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000565	0.00173	CbGpPWpGaD
Flurazepam—GABRB3—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000562	0.00172	CbGpPWpGaD
Flurazepam—GABRA4—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000561	0.00172	CbGpPWpGaD
Flurazepam—GABRA4—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000561	0.00172	CbGpPWpGaD
Flurazepam—GABRA2—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.000559	0.00171	CbGpPWpGaD
Flurazepam—GABRA6—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000557	0.00171	CbGpPWpGaD
Flurazepam—GABRB3—BDNF signaling pathway—SQSTM1—amyotrophic lateral sclerosis	0.000557	0.00171	CbGpPWpGaD
Flurazepam—GABRB3—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.000556	0.0017	CbGpPWpGaD
Flurazepam—GABRG2—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000552	0.00169	CbGpPWpGaD
Flurazepam—GABRB2—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000552	0.00169	CbGpPWpGaD
Flurazepam—GABRA4—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.00055	0.00169	CbGpPWpGaD
Flurazepam—GABRG2—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.000546	0.00167	CbGpPWpGaD
Flurazepam—ABCB1—central nervous system—amyotrophic lateral sclerosis	0.000546	0.00149	CbGeAlD
Flurazepam—GABRG3—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000543	0.00166	CbGpPWpGaD
Flurazepam—GABRA1—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.000541	0.00166	CbGpPWpGaD
Flurazepam—GABRA5—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000536	0.00164	CbGpPWpGaD
Flurazepam—GABRA1—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.000535	0.00164	CbGpPWpGaD
Flurazepam—GABRA1—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.000535	0.00164	CbGpPWpGaD
Flurazepam—GABRB1—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000535	0.00164	CbGpPWpGaD
Flurazepam—ABCB1—cerebellum—amyotrophic lateral sclerosis	0.000533	0.00145	CbGeAlD
Flurazepam—SLC22A2—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.000528	0.00162	CbGpPWpGaD
Flurazepam—GABRA3—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000526	0.00161	CbGpPWpGaD
Flurazepam—GABRA2—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000517	0.00158	CbGpPWpGaD
Flurazepam—CYP2A6—NRF2 pathway—SLC6A1—amyotrophic lateral sclerosis	0.000517	0.00158	CbGpPWpGaD
Flurazepam—GABRB3—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000514	0.00157	CbGpPWpGaD
Flurazepam—GABRB2—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000513	0.00157	CbGpPWpGaD
Flurazepam—GABRB2—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000513	0.00157	CbGpPWpGaD
Flurazepam—GABRA6—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000506	0.00155	CbGpPWpGaD
Flurazepam—GABRG2—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000505	0.00155	CbGpPWpGaD
Flurazepam—GABRB2—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000503	0.00154	CbGpPWpGaD
Flurazepam—GABRA4—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.0005	0.00153	CbGpPWpGaD
Flurazepam—GABRA1—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.000499	0.00153	CbGpPWpGaD
Flurazepam—GABRA5—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000498	0.00153	CbGpPWpGaD
Flurazepam—GABRA5—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000498	0.00153	CbGpPWpGaD
Flurazepam—SLC22A2—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.000497	0.00152	CbGpPWpGaD
Flurazepam—SLC22A2—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.000491	0.00151	CbGpPWpGaD
Flurazepam—SLC22A2—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.000491	0.00151	CbGpPWpGaD
Flurazepam—GABRR1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.00049	0.0015	CbGpPWpGaD
Flurazepam—GABRA3—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000489	0.0015	CbGpPWpGaD
Flurazepam—GABRA3—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000489	0.0015	CbGpPWpGaD
Flurazepam—GABRA5—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000489	0.0015	CbGpPWpGaD
Flurazepam—CYP2E1—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000483	0.00148	CbGpPWpGaD
Flurazepam—GABRA1—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000482	0.00148	CbGpPWpGaD
Flurazepam—GABRA2—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000481	0.00147	CbGpPWpGaD
Flurazepam—GABRA2—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000481	0.00147	CbGpPWpGaD
Flurazepam—GABRA3—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.00048	0.00147	CbGpPWpGaD
Flurazepam—GABRB3—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000478	0.00146	CbGpPWpGaD
Flurazepam—GABRB3—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000478	0.00146	CbGpPWpGaD
Flurazepam—GABRA1—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.000477	0.00146	CbGpPWpGaD
Flurazepam—GABRA2—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000472	0.00145	CbGpPWpGaD
Flurazepam—GABRG2—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000469	0.00144	CbGpPWpGaD
Flurazepam—GABRG2—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000469	0.00144	CbGpPWpGaD
Flurazepam—GABRB3—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000469	0.00144	CbGpPWpGaD
Flurazepam—SLC22A2—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.000468	0.00144	CbGpPWpGaD
Flurazepam—GABRQ—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000468	0.00143	CbGpPWpGaD
Flurazepam—GABRR2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000468	0.00143	CbGpPWpGaD
Flurazepam—GABRG2—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.00046	0.00141	CbGpPWpGaD
Flurazepam—SLC22A2—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.000458	0.0014	CbGpPWpGaD
Flurazepam—GABRB2—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000457	0.0014	CbGpPWpGaD
Flurazepam—GABRA5—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000444	0.00136	CbGpPWpGaD
Flurazepam—SLC22A2—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000443	0.00136	CbGpPWpGaD
Flurazepam—GABRA1—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000441	0.00135	CbGpPWpGaD
Flurazepam—SLC22A2—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.000438	0.00134	CbGpPWpGaD
Flurazepam—GABRA3—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000436	0.00134	CbGpPWpGaD
Flurazepam—ABCB1—brain—amyotrophic lateral sclerosis	0.000433	0.00118	CbGeAlD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—CASP12—amyotrophic lateral sclerosis	0.000432	0.00132	CbGpPWpGaD
Flurazepam—GABRA2—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000429	0.00131	CbGpPWpGaD
Flurazepam—GABRB3—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000426	0.0013	CbGpPWpGaD
Flurazepam—GABRB3—BDNF signaling pathway—BDNF—amyotrophic lateral sclerosis	0.000419	0.00129	CbGpPWpGaD
Flurazepam—GABRG2—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000418	0.00128	CbGpPWpGaD
Flurazepam—GABRR1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000417	0.00128	CbGpPWpGaD
Flurazepam—GABRR1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000417	0.00128	CbGpPWpGaD
Flurazepam—GABRA1—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.00041	0.00126	CbGpPWpGaD
Flurazepam—GABRA1—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.00041	0.00126	CbGpPWpGaD
Flurazepam—SLC22A2—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000405	0.00124	CbGpPWpGaD
Flurazepam—GABRA1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000402	0.00123	CbGpPWpGaD
Flurazepam—CYP2A6—NRF2 pathway—SQSTM1—amyotrophic lateral sclerosis	0.000399	0.00122	CbGpPWpGaD
Flurazepam—SLC22A2—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.000398	0.00122	CbGpPWpGaD
Flurazepam—GABRQ—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000398	0.00122	CbGpPWpGaD
Flurazepam—GABRR2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000398	0.00122	CbGpPWpGaD
Flurazepam—GABRR2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000398	0.00122	CbGpPWpGaD
Flurazepam—GABRQ—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000398	0.00122	CbGpPWpGaD
Flurazepam—GABRG3—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000385	0.00118	CbGpPWpGaD
Flurazepam—GABRB1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.00038	0.00116	CbGpPWpGaD
Flurazepam—SLC22A2—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000376	0.00115	CbGpPWpGaD
Flurazepam—SLC22A2—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000376	0.00115	CbGpPWpGaD
Flurazepam—GABRR1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000372	0.00114	CbGpPWpGaD
Flurazepam—SLC22A2—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000369	0.00113	CbGpPWpGaD
Flurazepam—GABRA1—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000365	0.00112	CbGpPWpGaD
Flurazepam—GABRA6—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000359	0.0011	CbGpPWpGaD
Flurazepam—SLC22A2—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.000355	0.00109	CbGpPWpGaD
Flurazepam—GABRR2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000355	0.00109	CbGpPWpGaD
Flurazepam—GABRA4—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000355	0.00109	CbGpPWpGaD
Flurazepam—GABRQ—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000355	0.00109	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—RARA—amyotrophic lateral sclerosis	0.000352	0.00108	CbGpPWpGaD
Flurazepam—ABCB1—Allograft Rejection—CASP9—amyotrophic lateral sclerosis	0.000346	0.00106	CbGpPWpGaD
Flurazepam—GABRA1—SIDS Susceptibility Pathways—BDNF—amyotrophic lateral sclerosis	0.000338	0.00103	CbGpPWpGaD
Flurazepam—SLC22A2—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000336	0.00103	CbGpPWpGaD
Flurazepam—GABRG3—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000328	0.001	CbGpPWpGaD
Flurazepam—GABRG3—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000328	0.001	CbGpPWpGaD
Flurazepam—GABRB2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000324	0.000994	CbGpPWpGaD
Flurazepam—GABRB1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000323	0.000989	CbGpPWpGaD
Flurazepam—GABRB1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000323	0.000989	CbGpPWpGaD
Flurazepam—CYP2A6—Fluoropyrimidine Activity—TP53—amyotrophic lateral sclerosis	0.000316	0.000968	CbGpPWpGaD
Flurazepam—GABRA5—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000315	0.000965	CbGpPWpGaD
Flurazepam—CYP2A6—NRF2 pathway—GSTP1—amyotrophic lateral sclerosis	0.000312	0.000955	CbGpPWpGaD
Flurazepam—GABRA3—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000309	0.000948	CbGpPWpGaD
Flurazepam—GABRA6—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000305	0.000936	CbGpPWpGaD
Flurazepam—GABRA6—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000305	0.000936	CbGpPWpGaD
Flurazepam—GABRA2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000304	0.000932	CbGpPWpGaD
Flurazepam—GABRB3—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000302	0.000926	CbGpPWpGaD
Flurazepam—GABRA4—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000301	0.000924	CbGpPWpGaD
Flurazepam—GABRA4—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000301	0.000924	CbGpPWpGaD
Flurazepam—GABRG2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000297	0.000909	CbGpPWpGaD
Flurazepam—GABRG3—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000292	0.000895	CbGpPWpGaD
Flurazepam—GABRB1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000288	0.000881	CbGpPWpGaD
Flurazepam—ABCB1—Allograft Rejection—CD40LG—amyotrophic lateral sclerosis	0.000279	0.000854	CbGpPWpGaD
Flurazepam—GABRB2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000276	0.000845	CbGpPWpGaD
Flurazepam—GABRB2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000276	0.000845	CbGpPWpGaD
Flurazepam—CYP2A6—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000273	0.000838	CbGpPWpGaD
Flurazepam—GABRA6—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000272	0.000834	CbGpPWpGaD
Flurazepam—GABRA4—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000269	0.000823	CbGpPWpGaD
Flurazepam—GABRA5—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000268	0.000821	CbGpPWpGaD
Flurazepam—GABRA5—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000268	0.000821	CbGpPWpGaD
Flurazepam—GABRA3—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000263	0.000806	CbGpPWpGaD
Flurazepam—GABRA3—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000263	0.000806	CbGpPWpGaD
Flurazepam—GABRA1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000259	0.000794	CbGpPWpGaD
Flurazepam—GABRA2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000259	0.000792	CbGpPWpGaD
Flurazepam—GABRA2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000259	0.000792	CbGpPWpGaD
Flurazepam—GABRB3—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000257	0.000787	CbGpPWpGaD
Flurazepam—GABRB3—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000257	0.000787	CbGpPWpGaD
Flurazepam—GABRG2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000252	0.000773	CbGpPWpGaD
Flurazepam—GABRG2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000252	0.000773	CbGpPWpGaD
Flurazepam—ABCB1—Allograft Rejection—C3—amyotrophic lateral sclerosis	0.000246	0.000755	CbGpPWpGaD
Flurazepam—GABRB2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000246	0.000753	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—MAPT—amyotrophic lateral sclerosis	0.000242	0.000742	CbGpPWpGaD
Flurazepam—GABRA5—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000239	0.000732	CbGpPWpGaD
Flurazepam—SLC22A2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000238	0.000729	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—CST3—amyotrophic lateral sclerosis	0.000235	0.00072	CbGpPWpGaD
Flurazepam—GABRA3—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000234	0.000718	CbGpPWpGaD
Flurazepam—GABRA2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.00023	0.000706	CbGpPWpGaD
Flurazepam—GABRB3—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000229	0.000701	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000228	0.0007	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000228	0.0007	CbGpPWpGaD
Flurazepam—GABRG2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000225	0.000689	CbGpPWpGaD
Flurazepam—CYP3A4—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000224	0.000687	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—IGFBP3—amyotrophic lateral sclerosis	0.000221	0.000678	CbGpPWpGaD
Flurazepam—GABRA1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.00022	0.000675	CbGpPWpGaD
Flurazepam—GABRA1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.00022	0.000675	CbGpPWpGaD
Flurazepam—CYP2E1—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000216	0.000662	CbGpPWpGaD
Flurazepam—CYP2E1—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000213	0.000653	CbGpPWpGaD
Flurazepam—GABRB3—BDNF signaling pathway—CASP3—amyotrophic lateral sclerosis	0.00021	0.000642	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—VAPB—amyotrophic lateral sclerosis	0.00021	0.000642	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—TPK1—amyotrophic lateral sclerosis	0.00021	0.000642	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000209	0.00064	CbGpPWpGaD
Flurazepam—SLC22A2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000202	0.00062	CbGpPWpGaD
Flurazepam—SLC22A2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000202	0.00062	CbGpPWpGaD
Flurazepam—ABCB1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000202	0.000618	CbGpPWpGaD
Flurazepam—GABRA1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000196	0.000602	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000194	0.000595	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000192	0.000587	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000182	0.000559	CbGpPWpGaD
Flurazepam—SLC22A2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.00018	0.000553	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000178	0.000546	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—CASP9—amyotrophic lateral sclerosis	0.000171	0.000524	CbGpPWpGaD
Flurazepam—GABRA1—SIDS Susceptibility Pathways—CASP3—amyotrophic lateral sclerosis	0.000169	0.000517	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000168	0.000513	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000166	0.000507	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000166	0.000507	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—DAO—amyotrophic lateral sclerosis	0.000165	0.000506	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—DAO—amyotrophic lateral sclerosis	0.000152	0.000464	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000151	0.000464	CbGpPWpGaD
Flurazepam—ABCB1—Allograft Rejection—CASP3—amyotrophic lateral sclerosis	0.000146	0.000447	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	0.000144	0.000441	CbGpPWpGaD
Flurazepam—GABRA1—SIDS Susceptibility Pathways—VEGFA—amyotrophic lateral sclerosis	0.000143	0.000439	CbGpPWpGaD
Flurazepam—ABCB1—HIF-1-alpha transcription factor network—VEGFA—amyotrophic lateral sclerosis	0.000143	0.000438	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000141	0.000431	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	0.000138	0.000421	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000132	0.000406	CbGpPWpGaD
Flurazepam—ABCB1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.00013	0.000398	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000125	0.000383	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000125	0.000382	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000125	0.000382	CbGpPWpGaD
Flurazepam—ABCB1—Allograft Rejection—VEGFA—amyotrophic lateral sclerosis	0.000124	0.000379	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—DAO—amyotrophic lateral sclerosis	0.00012	0.000367	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—GSR—amyotrophic lateral sclerosis	0.000115	0.000354	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000115	0.000352	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000114	0.00035	CbGpPWpGaD
Flurazepam—ABCB1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000111	0.000339	CbGpPWpGaD
Flurazepam—ABCB1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000111	0.000339	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000106	0.000325	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—GSR—amyotrophic lateral sclerosis	0.000106	0.000325	CbGpPWpGaD
Flurazepam—CYP3A4—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.0001	0.000307	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—FIG4—amyotrophic lateral sclerosis	9.97e-05	0.000306	CbGpPWpGaD
Flurazepam—CYP3A4—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	9.89e-05	0.000303	CbGpPWpGaD
Flurazepam—ABCB1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	9.85e-05	0.000302	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—CHAT—amyotrophic lateral sclerosis	9.48e-05	0.00029	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	9.35e-05	0.000287	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—PLB1—amyotrophic lateral sclerosis	9.07e-05	0.000278	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—DAO—amyotrophic lateral sclerosis	9.02e-05	0.000276	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—CHAT—amyotrophic lateral sclerosis	8.7e-05	0.000267	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—GSR—amyotrophic lateral sclerosis	8.37e-05	0.000257	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	7.75e-05	0.000238	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—VAPB—amyotrophic lateral sclerosis	7.68e-05	0.000235	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—TPK1—amyotrophic lateral sclerosis	7.68e-05	0.000235	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	7.2e-05	0.000221	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—VAPA—amyotrophic lateral sclerosis	7.03e-05	0.000215	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—CHAT—amyotrophic lateral sclerosis	6.88e-05	0.000211	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—PLB1—amyotrophic lateral sclerosis	6.83e-05	0.000209	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—SACM1L—amyotrophic lateral sclerosis	6.53e-05	0.0002	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—GSR—amyotrophic lateral sclerosis	6.31e-05	0.000193	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—FIG4—amyotrophic lateral sclerosis	6.14e-05	0.000188	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	6.11e-05	0.000187	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	5.56e-05	0.00017	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—CHAT—amyotrophic lateral sclerosis	5.18e-05	0.000159	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—GSTP1—amyotrophic lateral sclerosis	5.09e-05	0.000156	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.68e-05	0.000143	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.68e-05	0.000143	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	4.61e-05	0.000141	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.3e-05	0.000132	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	4.21e-05	0.000129	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	3.89e-05	0.000119	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—APOE—amyotrophic lateral sclerosis	3.85e-05	0.000118	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.7e-05	0.000113	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—APOE—amyotrophic lateral sclerosis	3.54e-05	0.000108	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.4e-05	0.000104	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	3.19e-05	9.78e-05	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—APOE—amyotrophic lateral sclerosis	2.79e-05	8.56e-05	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.78e-05	8.53e-05	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.64e-05	8.09e-05	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.56e-05	7.84e-05	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.42e-05	7.42e-05	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—APOE—amyotrophic lateral sclerosis	2.1e-05	6.45e-05	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.91e-05	5.87e-05	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.71e-05	5.25e-05	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.58e-05	4.83e-05	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.44e-05	4.42e-05	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	1.3e-05	3.97e-05	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	8.88e-06	2.72e-05	CbGpPWpGaD
